Saturday, September 18, 2021
A Food and Drug Administration advisory panel voted unanimously on Friday in favor of a booster dose of the Pfizer-BioNTech Covid-19 vaccine for people 65 and older and for individuals at high risk for severe disease, with the shot given at least six months after their initial vaccination.
Admin's note: Participants in this discussion must follow the site's moderation policy. Profanity will be filtered. Abusive conduct is not allowed.